Patterns of Cardiac Arrhythmia in Patients With Chronic Kidney Disease
Starting soon
Conditions studied: Chronic Kidney Disease With and Without Hemodialysis
In brief
Cardiovascular diseases remain the primary leading cause of death in patients on maintenance hemodialysis accounting for nearly 41% of deaths. Chronic kidney disease is associated with an excess of acquired arrhythmia of multiple types, and atrial fibrillation in particular. Sudden cardiac death is also more common in chronic kidney disease and accounts for around one- quarter of deaths in dialysis patients. The aim of the study is to evaluate the incidence, describe the patterns of cardiac arrhythmia and to determine the factors predisposing to cardiac arrhythmia in patients with chronic kidney disease with or without hemodialysis.
Key facts
- Study ID
- NCT07640919
- Run by
- Sohag University
- People needed
- 200
- Starts
- 2026-07-20
- Expected to finish
- 2027-01-20
- Last updated by the study team
- 2026-06-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with CKD (no intercurrent illness or uremic symptoms, and not hospitalized in the previous 3 months) with renal replacement therapy on maintenance HD (three times/week for at least three months) or without renal replacement therapy, aged 18 or above.
You may not qualify if…
- Patients aged <18 years old.
- Patients on drugs that are known to prolong the QT interval (e.g., antibiotics as clarithromycin, antifungal as fluconazole, antiarrhythmics as amiodarone, antipsychotic as chlorpromazine)
- Patients with structural heart diseases (e.g.,significant valvular lesions )
- Patients with impaired left ventricular systolic functions (defined as EF< 50%
- Patients with malignancy, severe infection or sepsis.
- Patients with major bleeding.
Where it is running
- Sohag university hospitals — Sohag, ElKholy, Egypt
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.